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INTRODUCTION
Intracranial tuberculoma is a rare condition and is one of
the causes of intracranial mass lesions. However, its reported
incidence varies, from 0.15% to 30% in intracranial mass
lesions (1, 2). Intracranial tuberculoma is a serious and fatal
disease, but its frequency has increased in recent years due
to its occurrence in immune-compromised hosts (3). The
diagnosis of intracranial tuberculoma is often difficult because
conventional magnetic resonance (MR) imaging of tubercu-
loma reveals various findings. In addition, it requires differ-
ential diagnosis with metastatic tumors, abscesses, malignant
brain tumors, and other brain lesions that can be associated
with acute myeloid leukemia (AML) (4). Moreover, neuro-
logical symptoms are not typical (5).
We describe an interesting case of intracranial tuberculo-
ma that subsided after anti-tuberculous medication in a pa-
tient with AML.
CASE REPORT 
A 52-yr-old man visited our hospital and was diagnosed
with AML in June 2006. Bone marrow aspiration revealed
75% blasts, and the French American British classification
was M2. Cytogenetic study showed normal chromosomes,
and the patient was classified into the intermediate-risk group.
Treatment with idarubicine (12 mg/m2 day 1-day 3) and
Ara-C (100 mg/m2, day 1-day 7) remission induction chemo-
therapy was initiated. During induction chemotherapy, the
patient experienced a neutropenic fever, and empirical anti-
biotics were administered to treat anal abscesses. After the
first course of induction chemotherapy, the patient achieved
complete remission, and we treated him with three times
high-dose Ara-C (2 g/m2 Bid, days 1, 3, 5) consolidation
chemotherapy sequentially. After the third cycle consolida-
tion treatment, he visited the outpatient department because
of right-side paresthesia in November 2006. The complete
blood count showed WBC 4,200/mL (normal, 4,800-10,800),
Hgb 11.3 g/dL (normal, 12-18), and platelet 160,000/mL
(normal, 130,000-450,000), and a leukemic relapse was not
suspected. For further evaluation of neurologic symptoms,
MR images of the brain were checked. The gadolinium-en-
hanced brain MR imaging showed multiple ring-enhanced
lesions with mild perilesional edema in the brain; the lesions
were located in the cerebrum, cerebellar hemispheres, and
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Multiple Intracranial Tuberculomas Mimicking Granulocytic Sarcomas
in Acute Myeloid Leukemia
The diagnosis of incracranial tuberculoma in immune-compromised hosts is often
difficult because conventional magnetic resonance (MR) imaging of tuberculoma
reveals various findings and neurologic symptoms are not typical. Here, we report
a case of a 54-yr old man with multiple intracranial tuberculoma who was treated
for acute myeloid leukemia. He complained of right-side paresthesia after the third
consolidation chemotherapy without leukemic relapse and fever. MR imaging of
the brain showed multiple ring-enhanced lesions in the cerebrum, cerebellar hemi-
sphere, and pons. The lesions appeared to mimic a metastatic tumor or abscess.
Cerebrospinal fluid analysis showed no abnormal cells, but the level of adenosine
deaminase was elevated (28.8 IU/L, normal 0-8). Stereotactic brain biopsy was
performed, but only reactive gliosis was observed. To confirm diagnosis, an open
brain biopsy was performed. The histopathology demonstrated chronic granuloma-
tous inflammation with caseous necrosis. Tuberculous-polymerase chain reaction
of the biopsy showed a positive result. He was treated with anti-tuberculosis medi-
cation and a high dose of steroid. Paresthesia improved, and follow-up brain MR
imaging showed the decreased size and numbers of ring-enhanced lesions and
improvement of perilesional edema 1 month after treatment. Here, we report on
an interesting case of intracranial tuberculoma in acute myeloid leukemia.
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pons. They were mostly located at the gray-white matter
junction (Fig. 1). For differential diagnosis of granulocytic
sarcomas, a bone marrow biopsy was performed. On the bone
marrow biopsy, focal abnormal cell clusters were observed
on the paratrabecular area, and showed a non-remission state.
Cerebrospinal fluid (CSF) analysis showed: pH 7.799, WBC
negative, protein 100 mg/dL (normal, 15-50), glucose 49 mg/
dL (normal, 40-70), and adenosine deaminase 28.8 IU/L (nor-
mal, 0-8). Mycobacterium tuberculosis polymerase chain
reaction (PCR) and India ink staining showed negative find-
ings.
To confirm diagnosis, a stereotactic brain biopsy was per-
formed, but only reactive gliosis was observed. An open brain
biopsy was then conducted. The gross finding showed a mass
with a central necrotic portion surrounded by hard wall. The
histopathological findings demonstrated chronic granuloma-
tous inflammation with tuberculous-PCR positivity, but acid-
fast bacilli staining was negative (Fig. 2). A routine chest
radiograph showed non specific findings. High-resolution
computed tomography (HRCT) was assessed because of the
possibility of pulmonary tuberculosis. However, HRCT show-
ed no abnormalities. The patient was treated with isoniazid,
rifampin, ethambutol, pyrazinamide, and high-dose steroid.
After treatment for 1 week, paresthesia improved. A follow-
up brain MR imaging after one month showed decreased size
and number of ring-enhanced lesions and improving perile-
sional edema. Therefore, we planned for anti-tuberculosis
maintenance treatment to be prolonged for about 9 months
as well as additional reinduction chemotherapy. 
DISCUSSION
Mortality and morbidity in patients with acute leukemia
is mainly related to relapse or infection. The cellular immu-
nity is extremely disrupted following high-dose chemother-
apy. Opportunistic infections from bacterial, viral, and fun-
gal pathogens can occur at this time (6). In areas where tuber-
culosis is endemic, the general population is exposed to the
tubercle bacillus throughout life. The dysregulation of im-
mune T-cells would render these patients immunologically
unable to defend themselves against Mycobacterium tuber-
culosis. The incidence of microbiologically tuberculous in-
fection in acute leukemia was reported about 2.2%, and the
most common site of tuberculous infection was the lung (6).
The intracranial tuberculomas in acute leukemia was not a
Fig. 1. T2-weighted axial image shows multiple ring-enhanced
masses with a high signal in the central portion and the perilesional
edema (left upper), and a gadolinium-enhanced T1-weighted
image shows multiple ring enhancement (right upper) (A). One
month after the initiation of anti-tuberculosis treatment, multiple
lesions in the brain showed decreased size and number with im-
proving perilesional edema (B).
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Fig. 2. Photomicro-
graph of histologic
examination dem-
onstrated granulo-
matous inflamma-
tion (A) and myco-
bacterium tubercu-
losis polymerase
chain reaction sho-
wed positive find-
ings (B).
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common infection site. Only 1% of immune-competent pa-
tients with tuberculosis develop an intracranial tuberculoma,
usually as part of miliary tuberculosis (7-9).
The diagnosis of intracranial tuberculomas is difficult to
make in immune-compromised patients, as misleading results
may arise from non specific symptoms (e.g., headache, fever,
weight loss, and weakness) (10). It is especially difficult to
distinguish symptoms of a brain tumor from those of an ab-
scess (e.g., seizure, headache, visual disturbance, and hemi-
paresis) (1, 11), and diagnosis of intracranial tuberculomas
based on radiographic and bacteriologic investigations is
also quite difficult (3, 12). Cultures of CSF of tuberculoma
are usually found to be negative (5), but positive PCR results
in the biopsied tissue are found in 60% to 80% of cases. In
most cases of intracranial tuberculomas, the initial clinical
diagnosis was a neoplasm. For this reason, clinicians must
always be aware of neoplasm, and should make the differen-
tial diagnosis from various tumorous conditions in the brain
(7, 10).
An association with pulmonary tuberculosis was reported
from 25% to 83% of cases, and 40% of patients had a his-
tory of tuberculosis (1, 2, 5, 11). Therefore, the patient his-
tory and findings on chest radiology should be taken together
in the diagnosis of intracranial tuberculomas.
Conventional MR imaging is very useful to detect small
lesions and to distinguish tuberculomas from other inflam-
matory lesions or brain tumors. A slightly hyperintense rim
with perilesional edema on T1-weighted images was also
described in pyogenic abscesses, and these findings are simi-
lar to those of tuberculomas. However, the hypointensity or
isointensity that is frequently seen in the central portions of
tuberculomas on T2-weighted images can be used to differ-
entiate tuberculomas from pyogenic abscesses (5). Diffusion-
weighted imaging of the brain showed homogeneous high
signals in tuberculomas. In our case, MR imaging of the
brain showed a similar finding of tuberculomas, but multi-
ple brain lesions and patient disease status (non-remission
state) were needed for differential diagnosis between tuber-
culomas to other brain tumors (metastatic tumors or granu-
locytic sarcomas) (4, 13, 14).
Many brain lesions could be associated with myeloid leu-
kemia, and the diagnosis was difficult to establish in this case
because of diffuse multiple parenchymal lesions mimicking
granulocytic sarcomas or abscesses (15). The case described
in this report was an interesting case of intracranial tubercu-
losis in AML.
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